Back
Sarepta Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$21.70
Seasonality Move:
6.08%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Sarepta Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.5 | Buy |
| 20-day SMA: | 21.62 | Buy |
| 50-day SMA: | 20.75 | Buy |
| 200-day SMA: | 30.1 | Sell |
| 8-day EMA: | 18.84 | Buy |
| 20-day EMA: | 11.91 | Buy |
| 50-day EMA: | 5.9 | Buy |
| 200-day EMA: | 1.65 | Buy |
Sarepta Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.06 | Buy |
| Relative Strength Index (14 RSI): | 54.13 | Buy |
| Chaikin Money Flow: | 1426024 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.03 - 22.43) | Buy |
| Bollinger Bands (100): | (17.92 - 22.36) | Buy |
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics, Inc. Stock
Is Sarepta Therapeutics, Inc. Stock a Buy?
-
Sarepta Therapeutics, Inc. share price is 21.82 while SRPT 8-day simple moving average is 21.50, which is a Buy signal.
-
The stock price of SRPT is 21.82 while Sarepta Therapeutics, Inc. 20-day SMA is 21.62, which makes it a Buy.
-
Sarepta Therapeutics, Inc. 50-day simple moving average is 20.75 while SRPT share price is 21.82, making it a Buy technically.
-
SRPT stock price is 21.82 and Sarepta Therapeutics, Inc. 200-day simple moving average is 30.10, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
43
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy or a Sell?
-
Sarepta Therapeutics, Inc. stock is rated a SellThe current Sarepta Therapeutics, Inc. [SRPT] share price is $21.82. The Score for SRPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics, Inc. Stock Info
Market Cap:
2.3B
Price in USD:
21.82
Share Volume:
2.7M
Sarepta Therapeutics, Inc. 52-Week Range
52-Week High:
129.84
52-Week Low:
10.42
Sell
43
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Sarepta Therapeutics, Inc. Share Price Forecast
-
What is the Sarepta Therapeutics, Inc. stock price today?The Sarepta Therapeutics, Inc. stock price is 21.82 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics, Inc. is overvalued.
Is Sarepta Therapeutics, Inc. Stock a Buy?
-
Sarepta Therapeutics, Inc. share price is 21.82 while SRPT 8-day exponential moving average is 18.84, which is a Buy signal.
-
The stock price of SRPT is 21.82 while Sarepta Therapeutics, Inc. 20-day EMA is 11.91, which makes it a Buy.
-
Sarepta Therapeutics, Inc. 50-day exponential moving average is 5.90 while SRPT share price is 21.82, making it a Buy technically.
-
SRPT stock price is 21.82 and Sarepta Therapeutics, Inc. 200-day simple moving average is 1.65, creating a Buy signal.
Fundamental Analysis of Sarepta Therapeutics, Inc.
Is Sarepta Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.02 per share, and an increase next year of $4.78 per share.
Technical Analysis of Sarepta Therapeutics, Inc.
Should I short Sarepta Therapeutics, Inc. stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is 6.06, suggesting Sarepta Therapeutics, Inc. is a Buy
-
Sarepta Therapeutics, Inc. Relative Strength Index (RSI) is 54.13, which suggest Sarepta Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Sarepta Therapeutics, Inc. is (20.03 - 22.43), which suggest Sarepta Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Sarepta Therapeutics, Inc. is (17.92 - 22.36), which suggest Sarepta Therapeutics, Inc. is a Buy
* Sarepta Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.